JP2008509224A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509224A5
JP2008509224A5 JP2007525717A JP2007525717A JP2008509224A5 JP 2008509224 A5 JP2008509224 A5 JP 2008509224A5 JP 2007525717 A JP2007525717 A JP 2007525717A JP 2007525717 A JP2007525717 A JP 2007525717A JP 2008509224 A5 JP2008509224 A5 JP 2008509224A5
Authority
JP
Japan
Prior art keywords
medicament
hydroxytyrosol
homocysteine
subject
rich
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509224A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028179 external-priority patent/WO2006020588A1/en
Publication of JP2008509224A publication Critical patent/JP2008509224A/ja
Publication of JP2008509224A5 publication Critical patent/JP2008509224A5/ja
Pending legal-status Critical Current

Links

JP2007525717A 2004-08-09 2005-08-09 炎症状態を治療するためのオリーブ組成物及び方法 Pending JP2008509224A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60023804P 2004-08-09 2004-08-09
US67246005P 2005-04-18 2005-04-18
PCT/US2005/028179 WO2006020588A1 (en) 2004-08-09 2005-08-09 Olive compositions and methods for treating inflammatory conditions

Publications (2)

Publication Number Publication Date
JP2008509224A JP2008509224A (ja) 2008-03-27
JP2008509224A5 true JP2008509224A5 (enExample) 2008-10-02

Family

ID=35907742

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525717A Pending JP2008509224A (ja) 2004-08-09 2005-08-09 炎症状態を治療するためのオリーブ組成物及び方法

Country Status (3)

Country Link
US (2) US20080300198A1 (enExample)
JP (1) JP2008509224A (enExample)
WO (1) WO2006020588A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2607977C (en) * 2005-05-09 2014-10-28 The Trustees Of The University Of Pennsylvania Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds
US9789149B2 (en) 2005-07-19 2017-10-17 Creagri, Inc. Vegetation water composition for treatment of inflammatory skin conditions
KR101435228B1 (ko) 2006-07-14 2014-08-28 디에스엠 아이피 어셋츠 비.브이. 조성물, 및 염증성 질환의 치료, 병용-치료 또는 예방을 위한 이의 용도
JP5175481B2 (ja) * 2006-10-23 2013-04-03 エーザイフード・ケミカル株式会社 軟骨再生促進剤
JP2008120716A (ja) * 2006-11-10 2008-05-29 Eisai Food Chemical Kk 抗炎症剤
CN101652130A (zh) * 2007-04-18 2010-02-17 帝斯曼知识产权资产管理有限公司 羟基酪醇和含有羟基酪醇的橄榄提取物/浓缩物的新颖用途
EP1982706A1 (en) * 2007-04-18 2008-10-22 DSMIP Assets B.V. Use of hydroxytyrosol for the treatment of cartilage injury
JP2011506397A (ja) * 2007-12-12 2011-03-03 ディーエスエム アイピー アセッツ ビー．ブイ． ヒドロキシチロソールおよびコンドロイチンを含む組成物ならびに炎症性障害の治療、併用治療または予防のためのその使用
US8796315B2 (en) 2009-06-25 2014-08-05 Darlene E. McCord Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
US8765794B2 (en) 2009-06-25 2014-07-01 Darlene McCord Compositions and methods for wound care
CA2769819C (en) 2009-08-10 2015-07-21 Darlene Mccord Nutritional supplements
US9144555B2 (en) 2012-11-30 2015-09-29 Darlene E. McCord Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
EP2934558A4 (en) * 2012-12-21 2016-07-27 Joel R L Ehrenkranz SUPPLEMENTS AND MONITORING SYSTEMS FOR SUPPLEMENT DOSING
ITMI20131815A1 (it) * 2013-10-31 2015-05-01 Fattoria La Vialla Di Gianni Anton Io E Bandino L Uso antinfiammatorio di fitocomplessi liquidi da olive
EP3626235B1 (en) * 2014-09-24 2023-12-13 Phytogen Medical Foods S.L. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
GR1008734B (el) 2014-11-26 2016-04-05 ΚΡΕΤΑ ΦΑΡΜ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ με δ.τ. "ΚΡΕΤΑ ΦΑΡΜ Α.Β.Ε.Ε." Υδατικο εκχυλισμα ελιας με μεταβολικες και καρδιο-προστατευτικες ιδιοτητες.
JP5956669B1 (ja) * 2015-12-18 2016-07-27 サンスター株式会社 低カロリーチョコレート組成物
US10342802B2 (en) 2016-10-04 2019-07-09 Nutramax Laboratories, Inc. Compositions comprising hydroxytyrosol and boswellic acid
WO2018067200A1 (en) * 2016-10-04 2018-04-12 Nutramax Laboratories, Inc. Compositions comprising hydroxytyrosol and boswellic acid
US11007171B2 (en) * 2017-07-13 2021-05-18 Summit Innovation Labs, LLC Treatment and prevention of joint disorders
EP3706759B1 (en) * 2017-11-08 2023-11-15 Société des Produits Nestlé S.A. Homovanillyl alcohol (hva), hva isomer, methods of making compositions comprising such compounds, and methods using such compounds
JP2020193852A (ja) * 2019-05-28 2020-12-03 株式会社ファンケル 非侵襲的な血清亜鉛値の推定方法
WO2022066513A1 (en) * 2020-09-24 2022-03-31 Mars, Incorporated Food compositions and applications thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522119A (en) * 1980-12-23 1985-06-11 Fps Development Partnership Olive oil recovery
US4452744A (en) * 1980-12-23 1984-06-05 Fps Development Partnership Olive oil recovery
US4370274A (en) * 1980-12-23 1983-01-25 Fps Development Partnership Olive oil recovery
EP0576420B1 (fr) * 1991-03-21 1995-05-31 Parfums Christian Dior Nouveau derive de l'acide cafeique, l'oraposide, composition cosmetique ou pharmaceutique, notamment dermatologique le contenant
WO1996014064A1 (en) * 1994-11-07 1996-05-17 Strecker, Robert, B. Method and composition for antiviral therapy
US5998641A (en) * 1997-01-31 1999-12-07 Unilever Patent Holdings Debittering of olive oil
US5714150A (en) * 1997-01-08 1998-02-03 Nachman; Leslie Method for producing extract of olive leaves
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
HUP0101529A3 (en) * 1998-04-14 2002-08-28 Unilever Nv Fortification of a vegetable fat with antioxidants
US6165475A (en) * 1998-07-23 2000-12-26 Creagri, Inc. Water-soluble extract from olives
MXPA01000776A (es) * 1998-07-23 2002-04-08 Creagri Inc Extracto de oliva soluble en agua.
US6936287B1 (en) * 1998-07-23 2005-08-30 Creagri, Inc. Water-soluble extract from olives
HUP0104840A2 (hu) * 1998-12-22 2002-04-29 Unilever N.V. Antioxidánsokkal dúsított élelmiszer kompozíciók
AU768306B2 (en) * 1999-10-14 2003-12-04 Nisshin Oil Mills, Ltd., The Skin-care agents, skin antiaging agents, whitening agents and external skin preparations
US6358542B2 (en) * 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
US6437004B1 (en) * 2000-04-06 2002-08-20 Nicholas V. Perricone Treatment of skin damage using olive oil polyphenols
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US7713569B2 (en) * 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
US6416808B1 (en) * 2000-09-01 2002-07-09 Creagri, Inc. Method of obtaining a hydroxytyrosol-rich composition from vegetation water
WO2002064537A1 (es) * 2001-02-15 2002-08-22 Consejo Superior De Investigaciones Cientificas Procedimiento de obtencion de hidroxitirosol purificado a partir de productos y subproductos derivados del olivo
US6734449B2 (en) * 2001-11-20 2004-05-11 Nexpress Solutions Llc Device for detecting the location of an edge of a transparent material, web edge control and printing press
AU2003223047A1 (en) * 2002-02-08 2003-09-02 Lavipharm S.A. Use of compounds and compositions derived form olives for protecting cells against dna damage
US6743449B2 (en) * 2002-02-13 2004-06-01 Skinceuticals, Inc. Topical composition comprising olive leaf extract
NZ534884A (en) * 2002-02-13 2007-05-31 Creagri Inc Method and composition for treatment of inflammation and AIDS-associated neurological disorders
ES2193874B1 (es) * 2002-04-03 2005-03-01 Puleva Biotech, S.A. Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
WO2005041999A1 (en) * 2003-10-21 2005-05-12 Motion Potion, Inc. Composition to enhance joint function and repair

Similar Documents

Publication Publication Date Title
GB0410266D0 (en) Treatment of apoptosis
EP4582099A3 (en) Methods of treating inflammatory and autoimmune diseases with natalizumab
JP2002522485A5 (enExample)
JP2020500864A5 (enExample)
Troester et al. Pediatric sleep pharmacology: a primer
Niino et al. Optimal clinical pathway for the patient with type B acute aortic dissection
JP2024026871A (ja) 慢性便秘症を治療するための医薬組成物
RU2384339C2 (ru) Применение симетикона для предрасположенных к запорам пациентов
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
Wawrzyniak et al. Comparison of clonidine and midazolam premedication before endoscopic sinus surgery: results of clinical trial
WO2020104987A1 (en) Composition for use in the prevention and/or symptomatic treatment of irritable bowel syndrome
Prousky The use of Niacinamide and Solanaceae (Nightshade) Elimination in the Treatment of Osteoarthritis.
US10179122B2 (en) Use of melatonin
US20220370347A1 (en) Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
JP2007112795A (ja) アントラキノン系薬剤含有下剤医薬組成物
KR20120015289A (ko) 피브레이트의 신규한 용도
JP2006282507A (ja) 下痢の予防および／または治療薬
Hansen The clinical diagnosis of acute rhinosinusitis and its therapeutic consequences
JP6032681B2 (ja) 排尿障害の予防・治療剤
Botea Analgesics
JP2006045200A (ja) 間質性膀胱炎の治療薬
Daneel Neulactil (pericyazine) in the behaviour disturbances of institutionalized mental defectives
EP2194979A1 (en) Treatment of cns and pain disorders
Murdoch et al. Management of Parkinson disease: defining the role of ropinirole
HUP0700383A2 (en) Use of b6, b12 vitamines, folic acid and rutosid for the prevention and treatment of venous trombosis